关注
Aleksander H. Erga
Aleksander H. Erga
Norwegian Centre for Movement Disorders
在 sus.no 的电子邮件经过验证 - 首页
标题
引用次数
年份
Personality traits as predictors of recovery among patients with substance use disorder
EC Fodstad, AH Erga, S Pallesen, A Ushakova, EK Erevik
Journal of Substance Use and Addiction Treatment 162, 209360, 2024
22024
The relationship between self-reported childhood maltreatment and mental health in substance use disorders: a 6-year retrospective analysis
AH Erga, A Ushakova, M Elstad, EC Fodstad, A Belfrage
Journal of dual diagnosis, 1-13, 2024
2024
Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders: a prospective longitudinal cohort study
J Hetland, AJ Lundervold, AH Erga
BMC psychiatry 24 (1), 143, 2024
22024
The interdependence of substance use, satisfaction with life, and psychological distress: a dynamic structural equation model analysis
FD Moe, A Erga, J Bjornestad, U Dettweiler
Frontiers in Psychiatry 15, 1288551, 2024
2024
Correction: Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders: a prospective longitudinal cohort study
J Hetland, AJ Lundervold, AH Erga
BMC psychiatry 24, 2024
2024
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention
AH Erga, J Hetland, K Braatveit
Frontiers in Psychiatry 14, 1281914, 2023
2023
Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease …
AH Erga, G Alves, AFG Leentjens
Contemporary Clinical Trials Communications 35, 2023
2023
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
L Oftedal, J Lange, KF Pedersen, AH Erga, I Dalen, OB Tysnes, G Alves, ...
Translational Neurodegeneration 12 (1), 41, 2023
2023
Performance on cognitive screening tests and long-term substance use outcomes in patients with polysubstance use disorder
J Hetland, E Hagen, AJ Lundervold, AH Erga
European Addiction Research 29 (2), 150-159, 2023
32023
The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease
AH Erga, G Alves, AFG Leentjens
Contemporary Clinical Trials Communications 32, 101080, 2023
22023
Traumatic experiences and PTSD symptoms in substance use disorder: A comparison of recovered versus current users
A Belfrage, AL Mjølhus Njå, S Lunde, J Årstad, EC Fodstad, TG Lid, ...
Nordic studies on alcohol and drugs 40 (1), 61-75, 2023
122023
Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s
L Oftedal, J Lange, KF Pedersen, AH Erga, I Dalen, OB Tysnes, G Alves, ...
2023
Personality and substance use disorder: Characteristics as measured by NEO-personality inventory–revised
EC Grude Fodstad, A Ushakova, S Pallesen, E Hagen, AH Erga, ...
Frontiers, 2022
2022
Personality and substance use disorder: Characteristics as measured by NEO-personality inventory–revised
EC Fodstad, A Ushakova, S Pallesen, E Hagen, AH Erga, EK Erevik
Frontiers in Psychology 13, 982763, 2022
42022
Persistent sleep problems among people in recovery from substance use disorders: a mixed methods study
AH Erga, S Nesvåg, IE Dahlberg, JR McKay
Addiction Research & Theory 30 (6), 422-430, 2022
22022
Cannabis use in Parkinson’s disease—A nationwide online survey study
AH Erga, J Maple‐Grødem, G Alves
Acta Neurologica Scandinavica 145 (6), 692-697, 2022
92022
Securing participant engagement in longitudinal substance use disorder recovery research: a qualitative exploration of key retention factors
TS Svendsen, M Veseth, JR McKay, J Bjornestad, AH Erga, C Moltu, ...
Journal of Psychosocial Rehabilitation and Mental Health 8, 247-259, 2021
82021
Prevalence and characteristics of borderline intellectual functioning in a cohort of patients with polysubstance use disorder
J Hetland, KJ Braatveit, E Hagen, AJ Lundervold, AH Erga
Frontiers in Psychiatry 12, 651028, 2021
132021
Trajectories of psychological distress during recovery from polysubstance use disorder
AH Erga, A Hønsi, LG Anda-Ågotnes, S Nesvåg, M Hesse, E Hagen
Addiction Research & Theory 29 (1), 64-71, 2021
302021
GWAS on impulse control disorders in Parkinson's disease: 462
S Bekadar, F Lejeune, F Danjou, M Vidailhet, M Anheim, A Elbaz, G Alves, ...
Movement Disorders 35 (S1), 194-195, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20